跳到正文
原文
Nature 健康护理主题·· 2026-10-19AI 评分43

早期肠内营养使用母乳、捐赠母乳或混合喂养对新生儿喂养里程碑的影响:一项横断面研究

Early enteral nutrition with mothers’ own milk, donor human milk, or a combination of both on neonatal feeding milestones: a cross-sectional study

AI 导读

一项横断面回顾性研究分析了极低出生体重早产儿使用纯母乳、纯捐赠母乳或混合喂养对喂养里程碑的影响。研究假设以100%捐赠母乳启动肠内营养会延长达到母乳强化及全肠内营养的时间,并增加静脉营养天数。该研究在CCMC针对2021至2024年间出生的婴儿进行了单中心数据分析。

正文

Introduction

Human milk (HM) is the gold standard for feeding premature infants, particularly very low birth weight (VLBW) infants born less than 32 weeks gestation [1,2,3,4]. The nutritional and protective benefits of HM are well established [1, 2]. Beneficial outcomes of HM feeding include a significant reduction in prematurity-related comorbidities, such as necrotizing enterocolitis (NEC) and late-onset sepsis, and shorter length of stay (LOS) [1, 4,5,6]. An exclusive HM diet has been shown to promote earlier achievement of neonatal feeding milestones, specifically HM fortification and full enteral nutrition (EN), and fewer days requiring parenteral nutrition (PN) [1,2,3]. Achieving full EN as quickly and safely as possible is ideal, to prevent PN complications [7, 8]. These feeding milestones and PN duration serve as critical indicators of an infant’s maturation and overall development [1, 2].

Beyond its nutritional composition, HM, specifically, mother’s own milk (MOM), is a dynamic biological fluid rich in bioactive components essential for immune protection and intestinal maturation [2, 3, 9, 10]. Colostrum contains the highest concentration of these properties, which gradually decline as HM transitions to mature HM [10, 11]. These bioactive factors are vital for immune system adaptation and play a pivotal role in establishing a healthy intestinal microbiome [10, 12, 13]. Since this process is dependent on colostrum, the impact of exposure to donor human milk (DHM) before MOM (colostrum) is unclear. Although not the aim of this study, this warrants further investigation.

When MOM is insufficient, pasteurized pooled DHM is the recommended alternative to infant formula [14,15,16,17]. However, critical differences exist between MOM and DHM that warrant careful consideration [1, 5]. DHM, typically collected from mothers of older infants, contains lower levels of bioactive components, protein, and fat than MOM [1, 2, 5, 11, 18]. Holder pasteurization further reduces immune cells, anti-inflammatory factors, and beneficial bacteria, leaving only some heat-stable components, whose concentrations and protective effects are diminished [1, 18,19,20].

The compositional disparity, coupled with the processing effects of pasteurization, raises critical questions about whether the protective benefits of DHM, especially immunomodulation and gut maturation, are equivalent to those of MOM [19, 20]. Current feeding practices promote earlier initiation of EN with DHM while waiting for MOM, to avoid formula, but this approach may inadvertently limit critical colostrum exposure [11, 14, 21, 22].

The increasing U.S. utilization of DHM in advanced-level neonatal care units (levels III and IV), from 28.7% in 2009, 54.7% in 2020, and greater than 95% in 2024, underscores the importance of assessing the impact of DHM versus MOM feeding on neonatal outcomes [23, 24]. The exact magnitude of protection offered by an exclusive DHM diet, particularly in the immediate postnatal period, when bioactive components are most critical, remains unclear [14, 25]. There is a paucity of research directly comparing clinical and nutritional outcomes between exclusive MOM, exclusive DHM, and mixed MOM/DHM feeding regimens [14].

This study aimed to explore outcomes associated with initiating early EN with exclusive MOM, compared to exclusive DHM, or a mix of both, on time to achieve HM fortification, full EN, and PN duration. Current evidence demonstrates that feeding any amount of MOM offers the best protection against morbidities associated with being born premature [11, 14, 26, 27]. However, like most studies comparing MOM to a DHM diet, the major limitation is that the DHM groups are often fed MOM as well [11, 14, 26, 27]. Therefore, no conclusion can be drawn if an exclusive DHM diet would demonstrate the same positive outcomes [11, 14, 27]. We hypothesized that initiating EN with 100% DHM would lead to a longer time to achieve HM fortification and full EN and be associated with increased PN days.

Methods

We conducted a single-center cross-sectional retrospective chart review involving VLBW premature infants born less than 32 weeks gestation between January 1, 2021, and December 31, 2024, at Cohen Children’s Medical Center of New York (CCMC), New Hyde Park, New York.

Exclusion criteria included transferred to CCMC at greater than 24 h of life, congenital anomaly, inborn error of metabolism, inability to receive HM, received at least one formula feed within study phase of initiation of EN until HM fortification, not receiving EN by 72 h of life, and development of a spontaneous intestinal perforation or NEC ≥ Bells Stage 2 before the initiation of the first enteral feed. The study was approved by both the Northwell Health and Rutgers University Institutional Review Board (IRB).

Study data were extracted retrospectively from the Northwell Health electronic medical record. Only deidentified data were exported to Statistical Package for Social Science (SPSS) version 30.0 (IBM Inc., Armonk, New York) for statistical analysis and did not include any patient identifiers.

Baseline infant demographic and clinical characteristics included birth weight (BW), gestational age, BW classification (small for gestational age, appropriate for gestational age, large for gestational age), sex, 5-min APGAR, oropharyngeal colostrum care, hour of life first EN feed was initiated, day of life first EN feed was initiated, day of life HM fortification, day of life full EN, and day of life PN was stopped after the normal transition from PN to full EN, NEC, late-onset sepsis, and LOS. Baseline fetal demographics and clinical characteristics included intrauterine growth restriction (IUGR), absent end-diastolic flow (AEDF), and reverse end-diastolic flow (REDF). Baseline maternal demographics and clinical characteristics included pregnancy-induced hypertension (PIH), gestational diabetes, and preeclampsia.

The primary outcomes were the number of days to reach HM fortification, the number of days to reach full EN, and the number of days requiring PN. PN initiation, advancement, and discontinuation, along with EN initiation and advancement, were according to the CCMC guidelines (Fig. 1). Enteral Nutrition was defined as any volume of MOM or DHM administered via gavage tube, including trophic feedings. At CCMC, oropharyngeal colostrum care was administered via a tuberculin syringe to the buccal surface of the oral mucosa and, therefore, was not counted towards EN. The number of days to reach HM fortification was defined as the number of days starting from the first day EN was initiated to the day of life the infant received at least half of the daily enteral volume of 24 calorie MOM/DHM with a commercial HM fortifier. There are various types of commercial HM fortifiers, including cow milk-based and human milk-based options, and the methods by which they are introduced can vary. Therefore, for the purpose of classifying the primary exposure variable (HM type), the study period for HM type assessment was defined as concluding at the time of HM fortification, allowing for a standardized evaluation of early, unfortified HM exposure. The assessment of subsequent feeding milestones (full EN, PN duration) continued beyond this point, but changes in HM type or fortifier use after HM fortification were not included in the definition of our primary HM type variable. The number of days to reach full EN was defined as the number of days starting from the first day EN was initiated to the day of life after PN was stopped, following the normal transition of PN to EN during the early neonatal period. The number of days requiring PN was defined as the total number of days the infant received PN during the normal transition from full PN to full EN, starting at birth until full EN was attained.

Fig. 1

Cohen Children’s Medical Center of New York neonatal feeding guidelines.

HM type was classified by percentage of each type of milk (MOM and/or DHM) out of the total enteral intake from the first enteral feed until HM fortification, thus dividing the milk intake into four groups: (1) 100% MOM, (2) 100% DHM, (3) DHM with ≥50% MOM, and (4) DHM with <50% MOM. When an infant received a combination of MOM and DHM, they were fed separately and recorded as such, allowing for the exact calculation of each.

Statistical analysis

Descriptive statistics were used to describe baseline infant, fetal, and maternal characteristics. Categorical variables were reported as frequency distributions (n, %). Continuous variables (BW, gestational age, hour of life first EN feed initiated, day of life first EN feed initiated, number of days to reach HM fortification, number of days to reach full EN, number of days requiring PN, and LOS) were reported as means and standard deviation (SD) for normally distributed data and as median and interquartile ranges (IQR) for data that were not normally distributed. The Shapiro-Wilk test, box plot, and Q-Q plot were used to assess the normality of the continuous data. The analysis was conducted on a complete dataset, and no data were missing for the variables of interest. Outliers were identified, but not removed, as their inclusion or exclusion did not significantly alter the final results.

Bivariate analyses, including independent samples t-test and correlation for continuous variables, and chi-square test for categorical variables, were used to identify potential covariates by examining the association between demographics and clinical characteristics, and the study outcomes. Based on bivariate analysis, clinical judgment, and review of the literature, gestational age, BW, 5-min APGAR, IUGR, and hour of life first EN feed were identified as control variables. Collinearity between independent variables was assessed, and gestational age and BW were found to be collinear. For statistical analysis, only BW was included in the model because it showed a stronger association with the outcome variables.

To analyze the impact of HM milk type on neonatal feeding milestones, a generalized linear model (GLM) with a negative binomial distribution and log link was used, given that the outcome variable was count data and showed overdispersion. To analyze the impact of HM type on the number of days to reach HM fortification and days requiring PN, a GLM model was fitted and adjusted for BW, IUGR, 5-min APGAR, and the hour of life of first EN feed. To analyze the impact of HM type on the number of days to reach full EN, the GLM included BW, IUGR, and 5-min APGAR as covariates. The hour of life of first EN feed was evaluated but excluded because it was not associated with this outcome variable.

An a priori power analysis was conducted using an analysis of covariance (ANCOVA) test in the G*Power software (version 3.1.9.7) to determine the minimum sample size required to test the study hypothesis based on the 4 covariates [BW, 5-min APGAR, IUGR, and the hour of life first feed] [28]. Results indicated the required sample size to achieve 80% power for detecting a medium effect size of 0.25, at a significance level of 0.05, with 4 groups was 179. Data were analyzed using SPSS version 30.0 (IBM Inc., Armonk, New York), and statistical significance was defined as a two-sided P value of less than 0.05.

Results

A total of 564 charts were initially reviewed. Of those, a total of 359 (63.7%) infants met the inclusion criteria (Fig. 2). Among the 359 infants (Table 1), the median gestational age was 28.9 (27.1–30.4) weeks, and the mean BW was 1060.5 ± 248.9 grams. Slightly more than half of the infants were female (52.9%), and the majority were classified as appropriate for gestational age (84.1%). The first EN feeding was initiated on average at 36.3 ± 15.5 h and day of life one (1.4 ± 0.7 days). Almost half of the infants received MOM as the first enteral feed (48.5%), and 16.2% of the infants received oropharyngeal colostrum care before the initiation of EN. Almost one third (29.8%) received exclusive MOM, 11.1% received exclusive DHM, and 59.1% received mixed feeding. HM fortification was achieved in 5.0 (4.0–7.0) days, full EN in 9.0 (7.0–11.0) days, and the median days requiring PN was 10.0 (9.0–13.0).

Fig. 2

Identification and inclusion rate of eligible infants.

Table 1 Demographic and clinical characteristics of the sample (N = 359).

Full size table

When baseline infant, fetal, and maternal characteristics were stratified by HM type (Table 2), statistically significant variables were BW, receiving oropharyngeal colostrum care before the first EN feed, days to HM fortification and full EN, and PN days. While infants fed 100% MOM had a higher incidence of oropharyngeal colostrum care before the first EN feed (24.3%), they also had (in this statistical analysis) a longer time to HM fortification, full EN, and PN days. The mean BW was lowest in the 100% MOM group (988.9 ± 252.1 grams). Feeding 100% MOM had the longest time to the first feed (39.5 h) compared to infants fed 100% DHM (34.2 h)(P = 0.082). Although not statistically significant (P = 0.068), the 100% MOM group had a higher incidence of 5-min APGAR score ≤6 (15.9%), versus the DHM with ≥ 50% MOM group (5.1%). The lowest percentage of NEC was observed in the 100% MOM (9.3%) and DHM with ≥50% MOM (5.1%) groups, but not statistically significant (P = 0.297). Feeding 100% MOM was also associated with the greatest number of days to achieve HM fortification [median (IQR): 6.0 days (4.0–7.0)], and full EN [9.0 days (8.0–13.00)] as well as days requiring PN [11.0 days (10.0–14.0)]. Lastly, infants who were fed 100% MOM had the longest LOS [67 days (48.0–87.8)], whereas the infants who were fed 100% DHM, had the shortest LOS [51.5 days (48.0–73.8)].

Table 2 Demographic and clinical characteristics by HM group type (N = 359).

Full size table

Table 3 represents the impact of HM type on neonatal feeding milestones after adjusting for covariates (BW, 5-min APGAR, IUGR, and hour of life first EN feed). No statistically significant differences were found across HM type for mean number of days to HM fortification (P = 0.787), mean number of days to full EN (P = 0.724), and mean number of days requiring PN during the early postnatal transition of PN to full EN (P = 0.701). However, feeding DHM with ≥ 50% MOM was associated with the longest time to achieve HM fortification (6.38 days), full EN (11.19 days), and the longest PN duration (12.71 days). Whereas feeding DHM with <50% MOM was associated with the shortest time to full EN (9.51 days) and shortest PN duration (10.77 days). Lastly, the 100% DHM fed group achieved HM fortification the fastest (5.35 days).

Table 3 Impact of human milk type on neonatal feeding milestones—adjusted for covariates (N = 359).

Full size table

Discussion

Our study was the first to our knowledge to investigate whether the type of HM feeding regimen (100% MOM, 100% DHM, or mixed MOM/DHM) impacts time to achieve HM fortification, full EN, and days requiring PN in VLBW infants born at less than 32 weeks gestation. We found no statistically significant differences among the HM type groups in the days to reach HM fortification, full EN, and the total number of days requiring PN during the early postnatal transition from PN to full EN, after adjusting for BW, 5-min APGAR, IUGR, and hour of life first EN feeding. Our findings did not support our original hypothesis that initiating EN with 100% DHM would lead to a longer time to reach feeding milestones (number of days to reach HM fortification and full EN) and be associated with an increased number of days requiring PN.

The lack of statistically significant differences between feeding exclusive MOM, exclusive DHM, or a combination of both, after adjusting for BW, 5-min APGAR, IUGR, and hour of life first EN feed, carries important clinical implications. These findings suggest that MOM and DHM may be equally beneficial in reaching key feeding milestones. This aligns with the current body of evidence supporting the clinical efficacy and safety of DHM [5, 14]. Our study further extends this understanding by demonstrating that, in the setting of feeding progression, the source and proportion of HM (MOM or DHM) did not introduce significant delays in the progression of key neonatal feeding milestones. These findings confirm that the benefits of an exclusive HM diet, MOM and/or DHM, along with standardized feeding protocols, play a substantial role in determining neonatal feeding-related outcomes.

Several interrelated factors may explain why the unadjusted data showed significant variations among the milk type groups; but, after adjusting for BW, IUGR, 5-min APGAR, and hour of life the first EN was given, the differences were no longer apparent. This underscores the substantial impact of these variables. Infants who are smaller or sicker are more likely to have a complicated clinical course, higher risk of mortality, severe morbidity, and poorer long-term neurodevelopmental outcomes [29,30,31]. BW is influenced by gestational age and fetal growth [32]. As gestational age decreases, premature infants are more likely to exhibit compromised digestive and absorptive functions [32, 33]. Neu et al. showed that with each one-week decrease in gestational age, 100 gram decrease in BW, or one point decrease in the five-minute APGAR score was associated with an eight to twenty percent likelihood of delayed feeding advancement [33]. In our study, the 100% MOM group had the lowest BW, which may offer one explanation as to why they took the longest to achieve HM fortification and full EN, required PN support the longest, and had the longest LOS. Larger studies analyzing the impact of HM type within specific BW or gestational age strata are needed to better understand whether neonatal feeding outcomes vary by degree of prematurity and growth restriction.

Additionally, the CCMC Neonatal Intensive Care Unit (NICU) feeding guidelines strongly emphasize early initiation and exclusive use of HM, incorporating DHM when MOM is unavailable or insufficient. Following standardized early feeding practices likely minimized potential differences that might otherwise arise from delayed initiation of EN.

Lastly, achieving an adequate supply of MOM in the early postnatal period can be challenging as lactogenesis can be delayed due to factors like delivery method, maternal stress, and preterm birth, resulting in limited MOM availability [18, 19]. According to CCMC feeding guidelines, infants are expected to receive a full 24 h of the prescribed EN volume before advancement. In the case of delayed lactogenesis or limited MOM, advancement before completing a full 24 h of the prescribed volume is at the clinician’s discretion. This may have inadvertently slowed or delayed feeding initiation and/or the rate of feeding advancement in the 100% MOM group.

Our findings have clinical implications for neonatal feeding practices. They offer reassurance to both clinicians and families that prioritizing HM feeding, including an exclusive DHM diet, does not impede EN feeding progression or extend PN duration. Moreover, these results reinforce current AAP and WHO recommendations to maximize HM feeding in preterm infants through the use of DHM as an alternative when MOM is insufficient or unavailable [15, 16]. This study strengthens the evidence supporting the integration of DHM programs into NICU protocols and reinforces the critical role of HM in the nutritional management of preterm infants [15, 16].

Limitations

While our study provides valuable insight, several limitations should be acknowledged. Causality generally cannot be established from a cross-sectional study. Our study was limited by the retrospective design; reliance on previously recorded clinical data introduces the possibility of inconsistently documented information. Despite statistical adjustments for key confounders, unmeasured or residual confounders could still have influenced the results. Our study did not analyze specific compositional differences between MOM and DHM nor assess the impact of these differences on feeding milestones. While our dataset does not explicitly isolate the feeding timelines of infants whose mothers refused DHM consent, this does represent a possible limitation as refusal of DHM could have introduced a delay in the time to initiate EN in the 100% MOM group. However, this confounding effect was mitigated by our study design; all infants must have received EN within the first 72 h of life, regardless of HM type. Our classification of HM type as a primary exposure variable was defined solely for the period up to HM fortification. Consequently, potential changes in the ratio of MOM to DHM, or the specific type of fortifier utilized after HM fortification, were not accounted for in our primary exposure variable. The study assessed only short-term feeding milestones and did not examine other important outcomes, such as gestational age effects, growth velocity, or neurodevelopment, where differences between MOM and DHM might be more pronounced or require larger sample sizes to detect. While rates of NEC and late-onset sepsis were reported, our study was not sufficiently powered to evaluate associations with these outcomes. Future large-scale prospective studies would be beneficial to address these limitations.

MOM is uniquely rich in bioactive components that contribute to intestinal maturation, immune priming, and mucosal protection [3, 9]. The clinical impact of these bioactive differences between MOM and DHM on the rate of achieving early neonatal feeding milestones might be less pronounced than their impact on longer-term outcomes, such as NEC and late-onset sepsis, as well as the development of the microbiome and immune response [7, 8]. While not achieving statistical significance, our study showed a compelling trend: infants who received higher proportions of MOM ( ≥ 50% to 100% MOM) were not only more likely to receive colostrum before the introduction of EN but also demonstrated the lowest percentage of NEC compared to the infants who received higher proportions of DHM (≥ 50% to 100% DHM). Though underpowered for NEC outcomes, these findings align with existing literature that supports the dose-dependent effect of MOM in NEC prevention [1, 14, 34]. This observation underscores the critical need for larger, adequately powered studies that aim to confirm the protective association and, importantly, investigate the consequences of not providing oropharyngeal colostrum care. Specifically, it should determine whether an exclusive DHM diet, in the absence of colostrum exposure, compromises NEC protection and early achievement of feeding milestones.

Our study had several strengths that bolster the reliability and clinical relevance of the findings. Our study focused on clinically meaningful and measurable feeding milestones, which are direct indicators of neonatal nutrition outcomes. Additionally, this study was conducted within a NICU that uses a standardized feeding protocol that prioritizes HM use. This practice minimized variability in feeding management, allowing for a clearer comparison of HM type groups and enhancing the generalizability of our findings.

Conclusion

Although MOM remains the gold standard due to its bioactive components, immunologic properties, and the distinct protective effects of colostrum, our study reinforces the value of DHM as a safe and effective alternative when MOM is unavailable or insufficient [1, 5]. HM provides essential nutrients and bioactive factors that support growth, gastrointestinal maturation, and immune development [14, 20]. Despite these known benefits, the specific influence of early EN with exclusive DHM or with varying combinations of MOM and DHM on the developing microbiome and immune system, and intestinal maturation, is not well understood [10, 35]. This process is dependent on colostrum and the impact of exposure to DHM before MOM still remains unclear and warrants future exploration.

BW and IUGR had a significant impact on the feeding outcomes [32, 33, 36]. As gestational age decreases, premature infants are more likely to have compromised digestive and absorptive function. Infants with low BW or IUGR are at increased risk for delayed achievement of full EN [32, 33, 36]. Larger studies are warranted to investigate the influence of HM type within specific BW and gestational age strata to determine whether neonatal feeding outcomes vary by degree of prematurity and growth restriction.

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author upon request.

References

  1. Maffei D, Schanler RJ. Human milk is the feeding strategy to prevent necrotizing enterocolitis!. Semin Perinatol. 2017;41:36–40.

    Article  PubMed  Google Scholar 

  2. Arslanoglu S, Boquien CY, King C, Lamireau D, Tonetto P, Barnett D, et al. Fortification of Human Milk for Preterm Infants: Update and Recommendations of the European Milk Bank Association (EMBA) Working Group on Human Milk Fortification. Front Pediatr. 2019;7:76.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163:1592–1595.e1591.

    Article  PubMed  Google Scholar 

  4. Reyes SM, Paul TL, Ferry J. Human milk fortification and necrotizing enterocolitis in very low birthweight infants: state of evidence and systematic review with meta-analysis. 2025;17:3384.

  5. Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V, et al. Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr. 2013;57:535–42.

    Article  PubMed  Google Scholar 

  6. Chandran S, Anand AJ, Rajadurai VS, Seyed ES, Khoo PC, Chua MC. Evidence-based practices reduce necrotizing enterocolitis and improve nutrition outcomes in very low-birth-weight infants. JPEN J Parenter Enter Nutr. 2021;45:1408–16.

    Article  Google Scholar 

  7. Coyne R, Hughes W, Purtill H, McGrath D, Dunne CP, Philip RK. Influence of an early human milk diet on the duration of parenteral nutrition and incidence of late-onset sepsis in very low birthweight (VLBW) infants: a systematic review. Breastfeed Med. 2024;19:425–34.

    Article  PubMed  Google Scholar 

  8. Miller M, Donda K, Bhutada A, Rastogi D, Rastogi S. Transitioning preterm infants from parenteral nutrition: a comparison of 2 protocols. JPEN J Parenter Enter Nutr. 2017;41:1371–9.

    Article  Google Scholar 

  9. Razzaghy J, Shukla VV, Gunawan E, Reeves A, Nguyen K, Salas AA. Early and exclusive enteral nutrition in infants born very preterm. Arch Dis Child Fetal Neonatal Ed. 2024;109:378.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Slouha E, Anderson ZS, Ankrah NMN, Kalloo AE, Gorantla VR. Colostrum and preterm babies: a systematic review. Cureus. 2023;15:e42021.

    PubMed  PubMed Central  Google Scholar 

  11. Parker LA, Koernere R, Fordham K, Bubshait H, Eugene A, Gefre A, et al. Mother’s own milk versus donor human milk: what’s the difference? Crit Care Nurs Clin North Am. 2024;36:119–33.

    Article  PubMed  Google Scholar 

  12. Cortez RV, Fernandes A, Sparvoli LG, Padilha M, Feferbaum R, Neto CM, et al. Impact of oropharyngeal administration of colostrum in preterm newborns’ oral microbiome. Nutrients. 2021;13:4224.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379–90.

    Article  PubMed  Google Scholar 

  14. Cartagena D, Penny F, McGrath JM, Reyna B, Parker LA, McInnis J. Differences in neonatal outcomes among premature infants exposed to mother’s own milk versus donor human milk. Adv Neonatal Care. 2022;22:539–49.

    Article  PubMed  Google Scholar 

  15. Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States. Pediatrics. 2017;139:e20163440.

  16. Guidelines on Optimal Feeding of Low Birth-Weight Infants in Low- and Middle-Income Countries. World Health Organization. Copyright © 2011, World Health Organization. Geneva, 2011.

  17. World Health Organization: Infant and young child feeding. Breastfeeding recommendation. Updated December 20, 2023. [cited January 9, 2026]Available from: https://www.who.int/health-topics/breastfeeding#tab=tab_2.

  18. Gates A, Hair AB, Salas AA, Thompson AB, Stansfield BK. Nutrient composition of donor human milk and comparisons to preterm human milk. J Nutr. 2023;153:2622–30.

    Article  PubMed  Google Scholar 

  19. Patil S, Ananthan A, Nanavati RN, Nataraj G, Prasad P. Effect of different methods of pasteurization on bactericidal action of human milk: A prospective observational study. Indian J Med Res. 2019;150:504–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ames SR, Lotoski LC, Azad MB. Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation. Gut Microbes. 2023;15:2190305.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chitale R, Ferguson K, Talej M, Yang W-C, He S, Edmond KM, et al. Early Enteral Feeding for Preterm or Low Birth Weight Infants: a Systematic Review and Meta-analysis. Pediatrics. 2022;150:e2022057092E.

    Article  PubMed  Google Scholar 

  22. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 2007;61:2–8.

    Article  PubMed  Google Scholar 

  23. Boundy EO, Anstey EH, Nelson JM. Donor Human Milk Use in Advanced Neonatal Care Units - United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71:1037–41.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Centers for Disease Control and Prevention. 2024 Maternity Practices in Infant Nutrition and Care (mPINC™) Survey. March 24, 2025. [cited June 16, 2026]Available from: https://www.cdc.gov/breastfeeding-data/mpinc/national-report.html.

  25. Ford SL, Lohmann P, Preidis GA, Gordon PS, O’Donnell A, Hagan J, et al. Improved feeding tolerance and growth are linked to increased gut microbial community diversity in very-low-birth-weight infants fed mother’s own milk compared with donor breast milk. Am J Clin Nutr. 2019;109:1088–97.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med. 2003;157:66–71.

    Article  PubMed  Google Scholar 

  27. Miller J, Tonkin E, Damarell RA, McPhee AJ, Suganuma M, Suganuma H, et al. A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients. 2018;10:707.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.

    Article  PubMed  Google Scholar 

  29. Martini S, Annunziata M, Della Gatta AN, Aceti A, Brunetti M, Pilu G, et al. Association between Abnormal Antenatal Doppler Characteristics and Gastrointestinal Outcomes in Preterm Infants. Nutrients. 2022;14:5121.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba’aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194:921–31.

    Article  PubMed  Google Scholar 

  31. Dorling J, Kempley S, Leaf A. Feeding growth restricted preterm infants with abnormal antenatal Doppler results. Arch Dis Child Fetal Neonatal Ed. 2005;90:F359–363.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Corvaglia L, Fantini MP, Aceti A, Gibertoni D, Rucci P, Baronciani D, et al. Predictors of full enteral feeding achievement in very low birth weight infants. PLoS One. 2014;9:e92235.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Neu J, Ashley P, Chowdhary V, Lampland A, Porcelli P, Rothstein R, et al. Progression of enteral feeding volumes in extremely low birth weight infants in the “Connection Trial. Am J Perinatol. 2024;41:e2717–e2726.

    Article  PubMed  Google Scholar 

  34. Gregory KE, Samuel BS, Houghteling P, Shan G, Ausubel FM, Sadreyev RI, et al. Influence of maternal breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. Microbiome. 2016;4:68.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 2013;60:49–74.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Patwardhan G, Soni A, Rachwani N, Kadam S, Patole S, Pandit A. Factors associated with time to full feeds in preterm very low birth weight infants. J Trop Pediatr. 2018;64:495–500.

    Article  PubMed  Google Scholar 

Download references

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

  1. Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Newark, NJ, USA

    Lyssa Lamport, Hamed Samavat, Allison Gomes, Melanie Newkirk, Laura Byham-Gray & Jane Ziegler

  2. Northwell Health, Cohen Children’s Medical Center of New York, Division of Neonatal-Perinatal Medicine, New York, NY, USA

    Lyssa Lamport

Authors

  1. Lyssa Lamport
  2. Hamed Samavat
  3. Allison Gomes
  4. Melanie Newkirk
  5. Laura Byham-Gray
  6. Jane Ziegler

Contributions

Lyssa Lamport, Jane Ziegler, Melanie Newkirk, Allison Gomes, Hamed Samavat, and Laura Byham-Gray contributed to the conception and design of the research; Lyssa Lamport contributed to the acquisition of the data; Lyssa Lamport, Jane Ziegler, Melanie Newkirk, Allison Gomes, Hamed Samavat, and Laura Byham-Gray contributed to the analysis and interpretation of the data; and Lyssa Lamport drafted the manuscript. All authors critically revised the manuscript, agreed to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.

Corresponding author

Correspondence to Jane Ziegler.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics

All methods were performed in accordance with the relevant guidelines and regulations. Approval was obtained from the Institutional Review Board of Rutgers University [IRB#Pro2025000677] and Northwell Health [IRB#25-0257]. Because this study was a retrospective review of existing medical records, the requirement for individual parental or maternal informed consent was formally waived. Patient confidentiality was strictly protected by analyzing only fully de-identified data. This research was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lamport, L., Samavat, H., Gomes, A. et al. Early enteral nutrition with mothers’ own milk, donor human milk, or a combination of both on neonatal feeding milestones: a cross-sectional study. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02928-y

Download citation

  • Received: 08 April 2026

  • Revised: 14 September 2026

  • Accepted: 29 September 2026

  • Published: 19 October 2026

  • Version of record: 19 October 2026

  • DOI: https://doi.org/10.1038/s41372-026-02928-y

来源:Nature 健康护理主题 · nature.com